TIM3 anticorps (AA 22-202)
Aperçu rapide pour TIM3 anticorps (AA 22-202) (ABIN7872291)
Antigène
Voir toutes TIM3 (TIM 3) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 22-202
-
Fonction
- HAVCR2 Antibody / TIM-3
-
Purification
- Protein A/G affinity
-
Immunogène
- A portion of amino acids 22-202 was used as the immunogen for the HAVCR2 antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the HAVCR2 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the HAVCR2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- TIM3 (TIM 3) (Hepatitis A Virus Cellular Receptor 2 (TIM 3))
-
Autre désignation
- HAVCR2
-
Sujet
- TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.
-
UniProt
- Q8TDQ0
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Cancer Immune Checkpoints
Antigène
-